CFDE Data Portal | Search LINC02746

	Label	Description
	LINC02746 Gene (Entity type)	ENSG00000282916 - long intergenic non-protein coding RNA 2746
	GSE119978 GSE180930 cisplatin 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978 GSE180930 cisplatin 6 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680 GSE182683 dexamethasone 7 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE264632 GSE264730 IDH1 inhibition 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE155031 catechin SH-SY5Y 6 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE213988 RRM2 knockdown 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE140076 dopamine 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

LINC02746

ENSG00000282916 - long intergenic non-protein coding RNA 2746

GSE119978 GSE180930 cisplatin 3 v 1 human dn

A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 6 v 7 human dn

A Gene Set from LINCS

GSE182680 GSE182683 dexamethasone 7 v 11 human up

A Gene Set from LINCS

GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 0 v 3 human up

A Gene Set from LINCS

GSE264632 GSE264730 IDH1 inhibition 0 v 2 human dn

A Gene Set from LINCS

GSE155031 catechin SH-SY5Y 6 v 0 human dn

A Gene Set from LINCS

GSE213988 RRM2 knockdown 0 v 1 human up

A Gene Set from LINCS

GSE140076 dopamine 0 v 2 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.